Kent Wangsness
YOU?
Author Swipe
View article: Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma
Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma Open
Objective: To evaluate the potential savings to health plans when the Pigmented Lesion Assay(PLA) is incorporated into the assessment of pigmented lesions clinically suspicious formelanoma.Methods: A Return on Investment (ROI) model was de…